Skip to main content

Alland Leila

In the past year, 2 open-market sale filings worth $157.0K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$157.0K
2 filings
Net
−$157.0K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Alland Leila as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ABEO Abeona Therapeutics Inc.

Director4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 2, 2026 (view filing)4:30 PM ETJun 302 daysAlland LeilaDirectorSSale−11.0K$5.92−$65.1K−6.3%162.6K after
Feb 2, 2026 (view filing)Feb 2Same dayAlland LeilaDirectorSSale−18.1K$5.09−$92.0K−9.4%173.6K after
May 20, 2024 (view filing)May 164 daysAlland LeilaDirectorPPurchase+11.0K$4.71+$51.8K+15.3%82.9K after
Sep 29, 2023 (view filing)Sep 272 daysAlland LeilaDirectorSSale−7.25K$3.90−$28.3K−9.2%71.9K after

PMVP PMV Pharmaceuticals, Inc.

Chief Medical Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2023 (view filing)Sep 153 daysAlland LeilaChief Medical OfficerSSale−6.29K$6.62−$41.6K−12.1%45.9K after
Sep 10, 2021 (view filing)Sep 91 dayAlland LeilaChief Medical OfficerSSale−100$30.25−$3.02K−100.0%0 after
Sep 8, 2021 (view filing)Sep 71 dayAlland LeilaChief Medical OfficerSSale−3.90K$30.25−$118.0K−100.0%0 after
Aug 10, 2021 (view filing)Aug 91 dayAlland LeilaChief Medical OfficerSSale−4.47K$34.04−$152.2K−100.0%0 after3 lots
Jul 8, 2021 (view filing)Jul 71 dayAlland LeilaChief Medical OfficerSSale−4.00K$32.30−$129.2K−100.0%0 after2 lots